17 May 2019 - - French video game studio Tilak Healthcare has inked an exclusive co-promotion partnership with Swiss pharmaceutical company Novartis' (SIX: NOVN) (NYSE: NVS) Novartis France business for OdySight, its first clinically validated mobile game to monitor vision remotely, the company said.

Tilak Healthcare will rely on medical representatives from Novartis France to inform ophthalmologists in France of this innovation and provide greater access to this solution.

Developed by physicians and video game professionals, OdySight is a concrete example of digital solutions to improve patient care.

By combining games and medical tests, the application allows close monitoring of patients with chronic ocular diseases (eg, AMD, diabetic macular edema, high myopia).

The user performs medical tests and then can progress through a puzzle game to test his cognitive and visual abilities.

In case of vision loss detected by the application, an alert is sent to the patient, inviting him to make an appointment with his ophthalmologist.

OdySight, as a fun and engaging application, motivates the patient to come back on a regular basis, and therefore, to do more visual tests, in a sustainable fashion, than are normally performed during a traditional care pathway.

Tilak is a videogame studio where people create mobile medical games for patients with chronic diseases.